Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency
- PMID: 22189657
- DOI: 10.1007/s00406-011-0281-8
Effects of ketamine-induced psychopathological symptoms on continuous overt rhyme fluency
Abstract
The N-methyl-D-aspartate receptor (NMDAR) has been implicated in the pathophysiology of schizophrenia. Administered to healthy individuals, a subanesthetic dose of the noncompetitive NMDAR antagonist ketamine reproduces several psychopathological symptoms commonly observed in patients with schizophrenia. In a counterbalanced, placebo-controlled, double-blind, within-participants study, fifteen healthy subjects were administered a continuous subanesthetic S-ketamine infusion while cortical activation was measured using functional magnetic resonance imaging. While being scanned, subjects performed an overt word generation task. Ketamine-induced psychopathological symptoms were assessed with the Positive and Negative Syndrome Scale (PANSS). Ketamine administration elicited effects on psychopathology, including difficulties in abstract thinking, lack of spontaneity and flow of conversation as well as formal thought disorder. On a behavioral level, verbal fluency performance was unaffected. The PANSS score for formal thought disorder positively correlated with activation measures encompassing the left superior temporal gyrus, the right middle and inferior frontal gyrus and the precuneus. Difficulty in abstract thinking was correlated with pronounced activations in prefrontal as well as in anterior cingulate regions, whereas hyperactivations in the left superior temporal gyrus were found in association with a lack of spontaneity and flow of conversation. In the absence of behavioral impairments during verbal fluency, NMDAR blocking evoked psychopathological symptoms and cortical activations in regions previously reported in schizophrenia patients. The results provide further support for the hypothesis of an NMDAR dysfunction in the pathophysiology of schizophrenia.
Similar articles
-
Neural correlates of S-ketamine induced psychosis during overt continuous verbal fluency.Neuroimage. 2011 Jan 15;54(2):1307-14. doi: 10.1016/j.neuroimage.2010.08.021. Epub 2010 Aug 18. Neuroimage. 2011. PMID: 20727411 Clinical Trial.
-
Effects of ketamine on prefrontal and striatal regions in an overt verbal fluency task: a functional magnetic resonance imaging study.Psychopharmacology (Berl). 2005 Nov;183(1):92-102. doi: 10.1007/s00213-005-0154-9. Epub 2005 Oct 22. Psychopharmacology (Berl). 2005. PMID: 16228196 Clinical Trial.
-
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.Arch Gen Psychiatry. 1994 Mar;51(3):199-214. doi: 10.1001/archpsyc.1994.03950030035004. Arch Gen Psychiatry. 1994. PMID: 8122957 Clinical Trial.
-
[Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine].Encephale. 2001 Jan-Feb;27(1):53-9. Encephale. 2001. PMID: 11294039 Review. French.
-
Glutamatergic Deficits in Schizophrenia - Biomarkers and Pharmacological Interventions within the Ketamine Model.Curr Pharm Biotechnol. 2018;19(4):293-307. doi: 10.2174/1389201019666180620112528. Curr Pharm Biotechnol. 2018. PMID: 29929462 Free PMC article. Review.
Cited by
-
Biomarkers and neurobiology of schizophrenia.Eur Arch Psychiatry Clin Neurosci. 2012 Aug;262(5):363-4. doi: 10.1007/s00406-012-0340-9. Eur Arch Psychiatry Clin Neurosci. 2012. PMID: 22743736 Free PMC article. No abstract available.
-
Effects of ketamine on brain function during smooth pursuit eye movements.Hum Brain Mapp. 2016 Nov;37(11):4047-4060. doi: 10.1002/hbm.23294. Hum Brain Mapp. 2016. PMID: 27342447 Free PMC article. Clinical Trial.
-
Ketamine pharmacology: an update (pharmacodynamics and molecular aspects, recent findings).CNS Neurosci Ther. 2013 Jun;19(6):370-80. doi: 10.1111/cns.12099. Epub 2013 Apr 10. CNS Neurosci Ther. 2013. PMID: 23575437 Free PMC article.
-
Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant.Behav Brain Res. 2020 Apr 20;384:112548. doi: 10.1016/j.bbr.2020.112548. Epub 2020 Feb 13. Behav Brain Res. 2020. PMID: 32061748 Free PMC article. Review.
-
Recent insights into the mode of action of memantine and ketamine.Curr Opin Pharmacol. 2015 Feb;20:54-63. doi: 10.1016/j.coph.2014.11.006. Epub 2014 Dec 2. Curr Opin Pharmacol. 2015. PMID: 25462293 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical